Trial Profile
Effects of Pharmacological Reversal of Hyperuricemia on Features of the Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Pharmacodynamics
- 18 Nov 2016 Status changed from recruiting to completed.
- 08 Aug 2012 New trial record